Samuel A. Roiko

599 total citations
15 papers, 466 citations indexed

About

Samuel A. Roiko is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Toxicology. According to data from OpenAlex, Samuel A. Roiko has authored 15 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Toxicology. Recurrent topics in Samuel A. Roiko's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Forensic Toxicology and Drug Analysis (4 papers). Samuel A. Roiko is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Forensic Toxicology and Drug Analysis (4 papers). Samuel A. Roiko collaborates with scholars based in United States, Vietnam and Germany. Samuel A. Roiko's co-authors include Daniel E. Keyler, Mark LeSage, Paul R. Pentel, Melanie A. Felmlee, Marilyn E. Morris, Andrew C. Harris, P.R. Pentel, Bridget L. Morse, Beverly Wical and John V. St. Peter and has published in prestigious journals such as Journal of Neuroscience, Journal of Pharmacology and Experimental Therapeutics and Pharmaceutical Research.

In The Last Decade

Samuel A. Roiko

15 papers receiving 459 citations

Peers

Samuel A. Roiko

CMN

PHYSI

TOXIC

PHARM

Morgan Le Naour United States

Nicolas Marie France

Donna Simcoe United States

Harshini Neelakantan United States

Jennifer Kuo United States

Deborah Barlow United States

Hsiang‐Wei Kuo Taiwan

Jessica M. Collins Australia

C A Branch United States

E Molina Italy

Morgan Le Naour United States

Samuel A. Roiko

166 ×0.8

225 ×1.5

CMN

102 ×0.7

PHYSI

98 ×0.9

TOXIC

99 ×1.4

PHARM

Citations per year, relative to Samuel A. Roiko Samuel A. Roiko (= 1×) peers Morgan Le Naour

Countries citing papers authored by Samuel A. Roiko

Since Specialization

Citations

This map shows the geographic impact of Samuel A. Roiko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel A. Roiko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel A. Roiko more than expected).

Fields of papers citing papers by Samuel A. Roiko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel A. Roiko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel A. Roiko. The network helps show where Samuel A. Roiko may publish in the future.

Co-authorship network of co-authors of Samuel A. Roiko

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel A. Roiko. A scholar is included among the top collaborators of Samuel A. Roiko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel A. Roiko. Samuel A. Roiko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Brown, Jacob T., et al.. (2022). Sertraline Dosing Trends in Children and Adolescents Stratified by CYP2C19 Genotype. Pharmacogenomics. 23(4). 247–253. 5 indexed citations

Salyakina, Daria, et al.. (2020). Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children’s Genomic Medicine Consortium. The Pharmacogenomics Journal. 21(1). 8–19. 25 indexed citations

Barney, Chantel C., Breanne J. Byiers, George L. Wilcox, et al.. (2017). A case‐controlled comparison of postoperative analgesic dosing between girls with Rett syndrome and girls with and without developmental disability undergoing spinal fusion surgery. Pediatric Anesthesia. 27(3). 290–299. 4 indexed citations

Wical, Beverly, et al.. (2016). Obstructive sleep apnea in children with cerebral palsy and epilepsy. Developmental Medicine & Child Neurology. 58(10). 1057–1062. 52 indexed citations

Burroughs, Danielle, et al.. (2015). Predictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy. Drug and Alcohol Dependence. 151. 181–193. 30 indexed citations

Roiko, Samuel A., et al.. (2013). Brain Extracellular γ-hydroxybutyrate Concentrations are Decreased by L-lactate in Rats: Role in the Treatment of Overdoses. Pharmaceutical Research. 30(5). 1338–1348. 16 indexed citations

Roiko, Samuel A., Melanie A. Felmlee, & Marilyn E. Morris. (2011). Brain Uptake of the Drug of Abuse γ-Hydroxybutyric Acid in Rats. Drug Metabolism and Disposition. 40(1). 212–218. 23 indexed citations

Felmlee, Melanie A., Samuel A. Roiko, Bridget L. Morse, & Marilyn E. Morris. (2010). Concentration-Effect Relationships for the Drug of Abuse γ-Hydroxybutyric Acid. Journal of Pharmacology and Experimental Therapeutics. 333(3). 764–771. 41 indexed citations

Felmlee, Melanie A., Qi Wang, Dapeng Cui, Samuel A. Roiko, & Marilyn E. Morris. (2010). Mechanistic Toxicokinetic Model for γ-Hydroxybutyric Acid: Inhibition of Active Renal Reabsorption as a Potential Therapeutic Strategy. The AAPS Journal. 12(3). 407–416. 22 indexed citations

10.

Riedl, Maureen, Patrick D. Braun, Kelley F. Kitto, et al.. (2009). Proteomic Analysis Uncovers Novel Actions of the Neurosecretory Protein VGF in Nociceptive Processing. Journal of Neuroscience. 29(42). 13377–13388. 47 indexed citations

11.

Roiko, Samuel A., Andrew C. Harris, Mark LeSage, Daniel E. Keyler, & Paul R. Pentel. (2009). Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats. Pharmacology Biochemistry and Behavior. 93(2). 105–111. 31 indexed citations

12.

Keyler, Daniel E., et al.. (2008). Enhanced immunogenicity of a bivalent nicotine vaccine. International Immunopharmacology. 8(11). 1589–1594. 53 indexed citations

13.

Roiko, Samuel A., Andrew C. Harris, Daniel E. Keyler, et al.. (2008). Combined Active and Passive Immunization Enhances the Efficacy of Immunotherapy against Nicotine in Rats. Journal of Pharmacology and Experimental Therapeutics. 325(3). 985–993. 31 indexed citations

14.

Pentel, Paul R., Michal Dufek, Samuel A. Roiko, Mark LeSage, & Daniel E. Keyler. (2006). Differential Effects of Passive Immunization with Nicotine-Specific Antibodies on the Acute and Chronic Distribution of Nicotine to Brain in Rats. Journal of Pharmacology and Experimental Therapeutics. 317(2). 660–666. 25 indexed citations

15.

Keyler, Daniel E., Samuel A. Roiko, Mark LeSage, et al.. (2005). MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS. Drug Metabolism and Disposition. 33(7). 1056–1061. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact